Related Experiment Videos
Insights
Complete resection of low-grade cystic cerebellar astrocytomas offers a 100% survival rate. For incomplete resections, postoperative radiation therapy significantly improves outcomes, achieving an 83% relapse-free survival rate.
Area of Science:
- Neuro-oncology
- Pediatric Neurosurgery
- Radiation Oncology
Background:
- Low-grade cystic cerebellar astrocytomas are a significant concern in pediatric neurosurgery.
- Treatment strategies have evolved, necessitating evaluation of their long-term efficacy.
Purpose of the Study:
- To evaluate the long-term outcomes of surgical resection and adjuvant radiation therapy for low-grade cystic cerebellar astrocytomas.
- To determine the impact of complete versus partial resection on patient survival and recurrence rates.
Main Methods:
- Retrospective analysis of 39 patients diagnosed with low-grade cystic cerebellar astrocytomas treated between 1955 and 1977.
- Comparison of outcomes between patients treated with partial or complete resection alone versus those receiving postoperative radiation therapy.
Main Results:
- Complete resection achieved a 100% survival rate and 82% relapse-free survival.
- Partial resection alone resulted in a significantly lower relapse-free survival rate of 36%.
- Postoperative radiation therapy following partial resection (for primary or recurrent disease) improved relapse-free survival to 83%.
Conclusions:
- Complete surgical excision is the optimal treatment for low-grade cystic cerebellar astrocytomas.
- Adjuvant postoperative radiation therapy is highly recommended following partial resection to improve outcomes and reduce recurrence.
Abstract:
Thirty-nine patients with low grade cystic cerebellar astrocytomas were treated at the University of Washington and Children's Orthopedic Hospital in Seattle, Washington, between 1955 and 1977; 29 were treated with partial or complete resection alone, and 10 received radiation therapy after various types of surgical procedures. With a mean follow-up time of 7 years, the survival rate for patients who had complete resections of their primary disease was 100%. The relapse-free survival rate was 82%. The relapse-free survival rate for patients treated primarily with partial resection alone was 36%. Postoperative irradiation after partial resection for both primary and recurrent disease resulted in a relapse-free survival rate of 83%. If complete tumor excision is not possible, postoperative radiation therapy is recommended following partial resection.